$815 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 95 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 56.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO INC | $67,058,000 | +25.7% | 2,628,678 | 0.0% | 8.22% | +1.6% | |
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $42,328,000 | +3.7% | 280,000 | 0.0% | 5.19% | -16.2% | |
| BLUE | Buy | BLUEBIRD BIO INC | $40,104,000 | +63.9% | 6,335,528 | +7.2% | 4.92% | +32.5% |
| TARS | Buy | TARSUS PHARMACEUTICALS INC | $35,778,000 | +17.6% | 2,089,856 | +0.3% | 4.39% | -5.0% |
| ALT | Sell | ALTIMMUNE INC | $33,208,000 | -21.2% | 2,600,450 | -27.8% | 4.07% | -36.3% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $29,779,000 | -25.5% | 640,000 | -8.6% | 3.65% | -39.8% |
| HRTX | Buy | HERON THERAPEUTICS INC | $28,865,000 | +178.1% | 6,840,000 | +83.9% | 3.54% | +124.8% |
| BIO | Buy | BIO RAD LABS INCcl a | $26,697,000 | -8.6% | 64,000 | +8.5% | 3.27% | -26.1% |
| KALV | KALVISTA PHARMACEUTICALS INC | $26,118,000 | +47.5% | 1,800,000 | 0.0% | 3.20% | +19.2% | |
| ALBO | Buy | ALBIREO PHARMA INC | $21,287,000 | +53.1% | 1,099,516 | +57.1% | 2.61% | +23.8% |
| RCKT | ROCKET PHARMACEUTICALS INC | $20,204,000 | +16.0% | 1,265,900 | 0.0% | 2.48% | -6.2% | |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $20,016,000 | – | 100,000 | +100.0% | 2.46% | – |
| IMCR | Buy | IMMUNOCORE HLDGS PLCads | $19,039,000 | +32.3% | 405,600 | +5.2% | 2.34% | +7.0% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $18,109,000 | +291.3% | 882,925 | +120.7% | 2.22% | +216.4% |
| ITOS | ITEOS THERAPEUTICS INC | $17,859,000 | -7.5% | 937,500 | 0.0% | 2.19% | -25.3% | |
| BCAB | Sell | BIOATLA INC | $15,146,000 | +57.6% | 1,967,051 | -41.7% | 1.86% | +27.3% |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $15,120,000 | +19.1% | 1,200,000 | 0.0% | 1.85% | -3.7% | |
| RLMD | RELMADA THERAPEUTICS INC | $14,808,000 | +94.9% | 400,000 | 0.0% | 1.82% | +57.5% | |
| BGNE | New | BEIGENE LTDsponsored adr | $14,156,000 | – | 105,000 | +100.0% | 1.74% | – |
| HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $13,730,000 | -6.2% | 310,000 | +3.3% | 1.68% | -24.1% |
| TWTR | New | TWITTER INC | $13,152,000 | – | 300,000 | +100.0% | 1.61% | – |
| VERU | Sell | VERU INC | $12,672,000 | -75.8% | 1,100,000 | -76.2% | 1.55% | -80.4% |
| INSM | New | INSMED INC | $10,770,000 | – | 500,000 | +100.0% | 1.32% | – |
| GLPG | Sell | GALAPAGOS NVspon adr | $9,592,000 | -31.2% | 224,950 | -10.0% | 1.18% | -44.4% |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $9,455,000 | +385.9% | 450,000 | +350.0% | 1.16% | +293.2% |
| IONS | IONIS PHARMACEUTICALS INC | $8,846,000 | +19.5% | 200,000 | 0.0% | 1.08% | -3.4% | |
| NKTX | Buy | NKARTA INC | $8,723,000 | +102.3% | 662,872 | +89.4% | 1.07% | +63.6% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $8,226,000 | – | 150,000 | +100.0% | 1.01% | – |
| ALLK | ALLAKOS INC | $8,099,000 | +95.5% | 1,323,393 | 0.0% | 0.99% | +58.1% | |
| DAWN | New | DAY ONE BIOPHARMACEUTICALS I | $8,012,000 | – | 400,000 | +100.0% | 0.98% | – |
| CGEM | Buy | CULLINAN ONCOLOGY INC | $8,000,000 | +2.4% | 624,016 | +2.4% | 0.98% | -17.2% |
| RVNC | New | REVANCE THERAPEUTICS INC | $7,763,000 | – | 287,500 | +100.0% | 0.95% | – |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $7,704,000 | +32.5% | 600,000 | 0.0% | 0.94% | +7.1% | |
| CHRS | COHERUS BIOSCIENCES INC | $7,208,000 | +32.7% | 750,000 | 0.0% | 0.88% | +7.3% | |
| IMGN | IMMUNOGEN INC | $7,170,000 | +6.2% | 1,500,000 | 0.0% | 0.88% | -14.2% | |
| ENTA | ENANTA PHARMACEUTICALS INC | $7,142,000 | +9.7% | 137,700 | 0.0% | 0.88% | -11.3% | |
| ASND | New | ASCENDIS PHARMA A/Ssponsored adr | $6,824,000 | – | 66,090 | +100.0% | 0.84% | – |
| TCRR | Buy | TCR2 THERAPEUTICS INC | $6,735,000 | -36.2% | 3,741,606 | +2.7% | 0.83% | -48.4% |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $6,720,000 | – | 1,003,017 | +100.0% | 0.82% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $5,819,000 | – | 585,424 | +100.0% | 0.71% | – |
| RCUS | ARCUS BIOSCIENCES INC | $5,232,000 | +3.2% | 200,000 | 0.0% | 0.64% | -16.5% | |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $5,075,000 | +163.0% | 3,500,000 | +231.9% | 0.62% | +112.3% |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $4,504,000 | – | 160,219 | +100.0% | 0.55% | – |
| GNFT | Sell | GENFIT S Aads | $4,371,000 | +7.6% | 1,197,522 | -5.1% | 0.54% | -13.0% |
| 2SEVENTY BIO INC | $4,365,000 | +10.2% | 300,000 | 0.0% | 0.54% | -11.0% | ||
| BNTX | Sell | BIONTECH SEsponsored ads | $4,046,000 | -32.2% | 30,000 | -25.0% | 0.50% | -45.2% |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $4,000,000 | -29.6% | 50,000 | 0.0% | 0.49% | -43.0% | |
| HSAQ | New | HEALTH SCIENCES ACQ CORP 2 | $3,886,000 | – | 392,500 | +100.0% | 0.48% | – |
| ALDX | New | ALDEYRA THERAPEUTICS INC | $3,738,000 | – | 700,000 | +100.0% | 0.46% | – |
| FBIO | Buy | FORTRESS BIOTECH INC | $3,607,000 | +28.5% | 4,194,483 | +25.5% | 0.44% | +3.8% |
| GRPH | GRAPHITE BIO INC | $3,487,000 | +15.3% | 1,100,000 | 0.0% | 0.43% | -6.8% | |
| SWTX | New | SPRINGWORKS THERAPEUTICS INC | $3,424,000 | – | 120,000 | +100.0% | 0.42% | – |
| ASLN | Buy | ASLAN PHARMACEUTICALS LTDads | $3,386,000 | +23.1% | 5,654,925 | +1.8% | 0.42% | -0.5% |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $3,350,000 | – | 500,000 | +100.0% | 0.41% | – |
| LIFE | ATYR PHARMA INC | $3,340,000 | +6.0% | 1,113,453 | 0.0% | 0.41% | -14.2% | |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $3,268,000 | – | 50,000 | +100.0% | 0.40% | – |
| LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $3,264,000 | +18.7% | 80,000 | +60.0% | 0.40% | -4.1% |
| ANIP | ANI PHARMACEUTICALS INC | $3,214,000 | +8.3% | 100,000 | 0.0% | 0.39% | -12.4% | |
| EGRX | New | EAGLE PHARMACEUTICALS INC | $3,140,000 | – | 118,857 | +100.0% | 0.38% | – |
| AXSM | New | AXSOME THERAPEUTICS INC | $3,123,000 | – | 70,000 | +100.0% | 0.38% | – |
| CLNN | New | CLENE INC | $3,080,000 | – | 1,100,000 | +100.0% | 0.38% | – |
| GOSS | New | GOSSAMER BIO INC | $2,995,000 | – | 250,000 | +100.0% | 0.37% | – |
| Buy | PYXIS ONCOLOGY INC | $2,781,000 | -15.3% | 1,411,569 | +2.4% | 0.34% | -31.5% | |
| BPMC | New | BLUEPRINT MEDICINES CORP | $2,636,000 | – | 40,000 | +100.0% | 0.32% | – |
| CCXI | CHEMOCENTRYX INC | $2,583,000 | +108.5% | 50,000 | 0.0% | 0.32% | +68.6% | |
| VNDA | VANDA PHARMACEUTICALS INC | $2,536,000 | -9.4% | 256,696 | 0.0% | 0.31% | -26.8% | |
| ADMA | New | ADMA BIOLOGICS INC | $2,413,000 | – | 992,840 | +100.0% | 0.30% | – |
| BEAM | New | BEAM THERAPEUTICS INC | $2,382,000 | – | 50,000 | +100.0% | 0.29% | – |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $2,162,000 | – | 409,463 | +100.0% | 0.26% | – |
| BLU | Sell | BELLUS HEALTH INC NEW | $2,112,000 | -61.9% | 200,000 | -66.7% | 0.26% | -69.2% |
| Sell | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $2,010,000 | +20.0% | 259,054 | -18.8% | 0.25% | -3.1% | |
| ALGS | Buy | ALIGOS THERAPEUTICS INC | $1,842,000 | -1.7% | 1,674,166 | +8.2% | 0.23% | -20.4% |
| CTIC | New | CTI BIOPHARMA CORP | $1,746,000 | – | 300,000 | +100.0% | 0.21% | – |
| Sell | TSCAN THERAPEUTICS INC | $1,702,000 | -27.6% | 557,915 | -25.4% | 0.21% | -41.5% | |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $1,504,000 | – | 200,000 | +100.0% | 0.18% | – |
| Sell | INSPIRATO INCORPORATED | $1,445,000 | -90.1% | 612,345 | -80.6% | 0.18% | -92.0% | |
| VINC | VINCERX PHARMA INC | $1,422,000 | +4.6% | 1,030,634 | 0.0% | 0.17% | -15.5% | |
| MRTX | New | MIRATI THERAPEUTICS INC | $1,397,000 | – | 20,000 | +100.0% | 0.17% | – |
| NKTR | NEKTAR THERAPEUTICS | $1,376,000 | -15.8% | 430,037 | 0.0% | 0.17% | -31.9% | |
| EQ | EQUILLIUM INC | $1,332,000 | +8.8% | 600,000 | 0.0% | 0.16% | -12.4% | |
| Sell | TRITIUM DCFC LIMITEDordinary shares | $1,276,000 | -58.1% | 400,000 | -20.0% | 0.16% | -66.2% | |
| LPTX | LEAP THERAPEUTICS INC | $1,100,000 | -23.5% | 1,250,000 | 0.0% | 0.14% | -38.1% | |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $1,044,000 | – | 100,000 | +100.0% | 0.13% | – |
| ORTX | ORCHARD THERAPEUTICS PLCspon ads | $1,000,000 | -14.4% | 2,000,000 | 0.0% | 0.12% | -30.5% | |
| ALEC | ALECTOR INC | $946,000 | -6.9% | 100,000 | 0.0% | 0.12% | -24.7% | |
| Buy | PARDES BIOSCIENCES INC | $925,000 | +121.8% | 500,000 | +267.7% | 0.11% | +79.4% | |
| ARVN | New | ARVINAS INC | $890,000 | – | 20,000 | +100.0% | 0.11% | – |
| OLMA | OLEMA PHARMACEUTICALS INC | $880,000 | -32.2% | 318,926 | 0.0% | 0.11% | -45.2% | |
| MTCR | New | METACRINE INC | $833,000 | – | 1,718,220 | +100.0% | 0.10% | – |
| FIXX | HOMOLOGY MEDICINES INC | $346,000 | -18.2% | 214,898 | 0.0% | 0.04% | -34.4% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $296,000 | -27.5% | 200,000 | 0.0% | 0.04% | -41.9% | |
| EOLS | New | EVOLUS INC | $294,000 | – | 36,514 | +100.0% | 0.04% | – |
| MOLN | New | MOLECULAR PARTNERS AGads | $105,000 | – | 15,681 | +100.0% | 0.01% | – |
| Sell | INSPIRATO INCORPORATED*w exp 02/11/2027 | $88,000 | -88.4% | 365,000 | -68.8% | 0.01% | -90.4% | |
| ACRX | New | ACELRX PHARMACEUTICALS INC | $81,000 | – | 388,468 | +100.0% | 0.01% | – |
| Exit | ROIVANT SCIENCES LTD | $0 | – | -101,404 | -100.0% | -0.06% | – | |
| RVPH | Exit | REVIVA PHARMACEUTCLS HLDGS I | $0 | – | -1,200,000 | -100.0% | -0.20% | – |
| Exit | TANGO THERAPEUTICS INC | $0 | – | -468,750 | -100.0% | -0.32% | – | |
| CRVS | Exit | CORVUS PHARMACEUTICALS INC | $0 | – | -3,301,709 | -100.0% | -0.50% | – |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -9,607,934 | -100.0% | -4.65% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERON THERAPEUTICS INC | 37 | Q3 2023 | 55.0% |
| LA JOLLA PHARMACEUTICAL CO | 34 | Q2 2022 | 37.1% |
| ROCKET PHARMACEUTICALS INC | 20 | Q3 2023 | 31.6% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2017 | 12.1% |
| ODONATE THERAPEUTICS INC | 17 | Q4 2021 | 69.8% |
| ANAPTYSBIO INC | 16 | Q3 2023 | 18.4% |
| COHERUS BIOSCIENCES INC | 15 | Q3 2023 | 2.7% |
| EQUILLIUM INC | 13 | Q3 2023 | 1.2% |
| RELMADA THERAPEUTICS INC | 12 | Q4 2022 | 6.2% |
| MIRATI THERAPEUTICS INC | 11 | Q3 2023 | 10.9% |
View TANG CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 4 | 2024-02-02 |
| 4 | 2023-12-18 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-13 |
| 13F-HR | 2023-08-14 |
| 3 | 2023-06-01 |
| 4 | 2023-06-01 |
| 4 | 2023-05-30 |
View TANG CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.